Ending tuberculosis in Gulf Cooperation Council countries: an overview of the WHO End TB Strategy 2025 milestones

Date
2025-06-06
Language
American English
Embargo Lift Date
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Elsevier
Can't use the file because of accessibility barriers? Contact us with the title of the item, permanent link, and specifics of your accommodation need.
Abstract

Objectives: Tuberculosis (TB) continues to pose a major global public health challenge. Although the Gulf Cooperation Council (GCC) countries have lower incidence rates of TB (<10 cases per million population), they are still striving to maintain and surpass benchmarks. We describe TB status to the 2025 milestones of the World Health Organization (WHO) End TB Strategy.

Methods: A retrospective study conducted using WHO data published from 2015 and between 2020 and 2023 highlights trends in TB incidence, mortality, treatment success, and drug resistance across GCC countries.

Results: Kuwait had the most significant drop in TB infections since 2015, with a reduction of 57%, followed by Qatar at 40% and Saudi Arabia at 31%. Oman, however, recorded a 23% increase. In terms of TB-related deaths, Saudi Arabia achieved a 32% decrease, whereas Qatar, Kuwait, and the United Arab Emirates experienced increases of 14%, 39%, and 22% respectively. Treatment success rates were highest in Qatar (100%), Oman (90%), and Saudi Arabia (87%), whereas Kuwait (44%) and Bahrain (77%) had the lowest rates. Oman reported the highest reduction in multidrug-resistant TB cases at (60%), followed by Saudi Arabia (50%), Kuwait (31%), and Bahrain (50%). Qatar had the highest increase (122%) and United Arab Emirates had no change, reflecting varying degrees of success in controlling drug-resistant TB. HIV-TB co-infection rates was highest in United Arab Emirates (5.4%) and Bahrain (5.1%), followed by Saudi Arabia (2.3%), Oman (1.4%), Qatar (0.6%), and Kuwait (0.5%). Notably, the GCC countries reported zero TB households, with no catastrophic overall expenses since 2020.

Conclusions: Although the GCC countries have made significant strides in TB control, their efforts toward the targets have been inconsistent, with notable differences in TB-related deaths, infection rates, treatment success, and multidrug-resistant TB rates. Strengthening regional collaboration, implementing targeted interventions, and integrating services are essential to meet the WHO's 2025 and 2035 goals.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Al Awaidy S, Khamis F, Al Mujeini S, Al Salman J, Al-Tawfiq JA. Ending tuberculosis in Gulf Cooperation Council countries: an overview of the WHO End TB Strategy 2025 milestones. IJID Reg. 2025;16:100681. Published 2025 Jun 6. doi:10.1016/j.ijregi.2025.100681
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
IJID Regions
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}